WHO reported “Tuberculosis (TB) as a communicable disease that is major cause of ill health and one of the leading causes of death worldwide. Until the coronavirus (COVID-19) pandemic, TB was the leading cause of death from a single infectious agent, ranking above HIV/AIDS. For the first time in over a decade, TB deaths have increased because of reduced access to TB diagnosis and treatment in the face of the COVID-19 pandemic. Close to half of the people ill with TB missed out on access to care in 2020 and were not reported. Furthermore, the number of people provided with treatment for drug-resistant TB and TB preventive treatment dropped significantly (Global WHO 2021 Report). In recognition of the enormous health, social and economic impacts of the COVID-19 pandemic, this report also includes the COVID-19 pandemic setbacks experienced and how they affected the TB response. Despite the observed setbacks caused by COVID-19, ACHAP was able to re-strategized the planned TB/HIV services effectively, leading to the overall success of the programme.
ACHAP’s TB Care and Prevention Programme has 4 specific activities:
The TB/HIV programme’s top priority during this reporting period was to restore access to and accelerate the provision of essential services to reduce the burden of TB and HIV in the community following the lessening of Covid-19 restriction such that, the vital TB treatment outcomes have improved to the acceptable levels. ACHAP embarked on the main mop-up community TB/HIV activities which include: active case finding, following contacts of all TB index patients, TB and ART loss to follow (defaulters) patients, missed appointments and interrupters as well as refer both PLHIV on Anti-Retroviral and Tuberculosis treatment interrupters for treatment re-initiation and or continuation to the nearest health facilities and ensure that they indeed, receive the recommended services.
This massive and vital exercise was conducted by CHWs (TB/HIV Volunteers) in the five (5) ACHAP supported districts, through door-to-door, outreach campaigns locally targeting hard to reach areas, farms, cattle posts, district’s neighbouring villages where most people had relocated during lockdowns. This exercise have saved the lives of ordinary individuals and communities by taking services to them as some index TB patients were identified, ART and TB interrupters and loss to follow as evidenced by the decrease in TB related mortality from 7% to 6% in 2021 and 2022 respectively. The incidence rate has been consistently low and assumed slight upward trend in the third quarter of 2022.
Early TB case identification, diagnosis, treatment initiation and cure, are the priority concerns for ACHAP in the fight against TB since it is only in this way that infectious sources can be eliminated to achieve a Botswana free of TB by 2030. The primary goal of TB screening was to reach people who were not reached by the initiated pathway to detect TB disease and initiate treatment early.
The number of new TB cases registered in 2022 had increased gradually per quarter up to the end of September, assuming the slight upward trend, compared to 2021. Out of 260 new TB cases registered in 2022, 161 (62%) were diagnosed & notified through the community health workers’ efforts as community referrals, against a Global Fund target of 47%, translating into an outstanding performance of 132%. 14 of the 161 notified TB cases were People living with HIV (PLHIV).
Figure 8 shows fluctuating trend of TB cases diagnosed and notified by Community Health Workers Volunteers through various TB screening approaches against target. Average performance was 62% with the highest being 69% percent in quarter 2 and the lowest being 44% in quarter 1.
The major role of Community TB/HIV Workers in this area was to offer routine HIV resting to all TB patients, refer them for testing, refer those who were TB/HIV co-infected to start ART and CPT to reduce opportunistic infections, promote treatment adherence, reduce the burden of TB and HIV disease, improve patients’ wellbeing and TB treatment outcome.
A higher percentage of people diagnosed with TB, were already on Anti-Retroviral Therapy (ART), this is an assurance that the “Treat All strategy” has made some strides in ensuring that all HIV positive patients are started on ART to improve their livelihood and wellbeing. During patient visitations for Directly observed therapy (DOT), TB/HIV co-infected patients are comprehensively supported for the two conditions, since they also need close monitoring for adherence purpose and observing for drug interactions, side effects for all drugs used, and the possibility of TB treatment failure or relapse. TB Treatment Supporters are oriented on these issues to maintain and sustain the required standard of care to all patients, including Drug Resistant TB cases.
Figure 9 below generally shows positive coverages against target. The coverages are high compared to the targets due to efficient patient education, counselling, effective referral system and cooperation of TB/HIV patients in general.
Figure 9: TB/HIV collaborative indicator performance: January – December 2022
Table 1: Treatment Care and Support Performance January – December 2022
The current data on figure 10 below indicates high levels of referral linkage to services amongst presumptive TB cases. Community Health Workers consistently track referred patients to complete referral. The consistent use of ACHAP integrated referral slip for all presumptive TB cases had tremendously improved referral success both for general population and PLHIV at Infectious Disease Care Clinic (IDCC). Follow-ups for referred patients were done frequently and sometimes accompanying some of the sickly patients to ensure they reach the facility.
Activity 4: TB Psychological and Social Support
ACHAP’s community-based TB interventions address patients’ needs comprehensively, including social, economic and other challenges, and are geared towards improving patients’ overall wellbeing and treatment outcomes. All TB patients starting on treatment are educated and counselled for a period of 2 weeks before they are eligible for community TB care. These patients are capacitated on TB/HIV, their roles and responsibilities as partners in care, treatment adherence expectations, as well as being assisted to accept their TB or TB/HIV statuses.
The current progress shows the impact that community TB/HIV health workers continue to make in the communities. They successfully bridge the gaps in contact tracing, enrolment of TB patients for Community TB Care, and provide effective implementation of TB/HIV collaborative activities.
The COVID-19 pandemic threatened to reverse recent progress made towards reducing the burden of TB disease if measures are not put in place.
Looking beyond the ACHAP Global Fund Phase 2 TB/HIV programme, there is a need to develop long-term sustainability through active implementation of a Behavioural Change Communication (BCC) strategy that will improve sharing, networking and internal and external relationships with communities and other partners implementing the TB/HIV programme for the betterment of the health status of the entire population in controlling and managing TB/HIV.